These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15800163)

  • 21. Risperidone, a risk factor for valproate-induced encephalopathy?
    Rodrigues-Silva N; Venâncio Â; Bouça J
    Gen Hosp Psychiatry; 2013; 35(4):452.e5-6. PubMed ID: 23317937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lithium intoxications at normal serum levels].
    Habermeyer B; Hess M; Kozomara-Hocke P; Mager R; Kawohl W
    Psychiatr Prax; 2008 May; 35(4):198-200. PubMed ID: 17987544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxic effects of nefazodone.
    Brazelton T; Blanc PD; Olson KR
    Ann Emerg Med; 1997 Oct; 30(4):550-1. PubMed ID: 9326873
    [No Abstract]   [Full Text] [Related]  

  • 24. Peripheral oedema in quetiapine therapy.
    McSkimming AJ; Dham P; Alexander J; Dinesh A
    Aust N Z J Psychiatry; 2012 Aug; 46(8):790-1. PubMed ID: 22848062
    [No Abstract]   [Full Text] [Related]  

  • 25. Predictors of valproic acid steady-state serum levels in adult and pediatric psychiatric inpatients: a comparative analysis.
    Avrahami M; Liwinski T; Eckstein Z; Peskin M; Perlman P; Sarlon J; Lang UE; Amital D; Weizman A
    Psychopharmacology (Berl); 2024 Sep; 241(9):1883-1894. PubMed ID: 38733528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stupor in a catatonic patient due to an interaction between high-dose lorazepam and valproic acid: a case report.
    de Neeling M; van Paesschen W
    Acta Neurol Belg; 2021 Aug; 121(4):1077-1078. PubMed ID: 34296394
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of hyperammonaemic encephalopathy due to valproic acid.
    Prins MC; van Meijel JJ
    Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, drug interactions, and tolerability of valproate.
    DeVane CL
    Psychopharmacol Bull; 2003; 37 Suppl 2():25-42. PubMed ID: 14624231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deconstructing a medication regimen.
    Preskorn SH
    J Psychiatr Pract; 2008 Mar; 14(2):114-8. PubMed ID: 18360197
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of hyperammonemic encephalopathy after 11 years of valproate therapy.
    Stewart JT
    J Clin Psychopharmacol; 2008 Jun; 28(3):361-2. PubMed ID: 18480705
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
    Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
    Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
    [No Abstract]   [Full Text] [Related]  

  • 32. Lithium-induced neurotoxicity: clinical presentations, pathophysiology, and treatment.
    Ivkovic A; Stern TA
    Psychosomatics; 2014; 55(3):296-302. PubMed ID: 24388123
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder.
    Muzyk AJ; Candeloro CL; Christopher EJ
    Gen Hosp Psychiatry; 2010; 32(5):560.e1-3. PubMed ID: 20851283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium-induced hypercalcemia and parathyroid dysfunction.
    Rifai MA; Moles JK; Harrington DP
    Psychosomatics; 2001; 42(4):359-61. PubMed ID: 11496029
    [No Abstract]   [Full Text] [Related]  

  • 35. Risperidone as an adjunct to valproic acid.
    Waring EW; Dewan VK; Cohen D; Grewal R
    Can J Psychiatry; 1999 Mar; 44(2):189. PubMed ID: 10097843
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperammonemia due to valproic acid in the psychiatric setting.
    Carr RB; Shrewsbury K
    Am J Psychiatry; 2007 Jul; 164(7):1020-7. PubMed ID: 17606652
    [No Abstract]   [Full Text] [Related]  

  • 37. Stuttering as a side-effect of divalproex sodium.
    Aukst-Margetić B; Margetić B
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):748. PubMed ID: 19068016
    [No Abstract]   [Full Text] [Related]  

  • 38. Infiltration of sodium valproate with compartment syndrome and bullous reaction: case report and literature review.
    Santivasi WL; Kulkarni S; Patton ML; Haith LR; Guilday RE; Reigart CL; Ackerman BH
    Burns; 2011 Nov; 37(7):e59-62. PubMed ID: 21715098
    [No Abstract]   [Full Text] [Related]  

  • 39. Lamotrigine might potentiate valproic acid-induced hyperammonemic encephalopathy.
    Fan CC; Huang MC; Liu HC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1747-8. PubMed ID: 18602440
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute akinetic crisis with marked cognitive impairment due to Valproate treatment.
    Reif A; Hamelbeck B; Pfuhlmann B
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):356-7. PubMed ID: 12673616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.